Can Wegovy Pill’s Rapid Uptake Give Novo Nordisk an Edge Over LLY?
Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…
Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success
The pharmaceutical industry is highly technical and incredibly competitive. That is on clear display right now in the…
GLP-1 drugs may have a beneficial effect across many types of cancer
By Nancy Lapid June 3 (Reuters) – A growing body of evidence suggests that popular GLP-1 drugs, widely…
Weight Loss Drugs Listed By Health Insurers Aren’t Necessarily Covered
Eli Lilly’s Foundayo weight loss oral pill competes against Novo Nordisk’s oral Wegovy. (Photo by: Michael Siluk/UCG/Universal Images…
Novo Nordisk faces complex GLP-1 landscape as oral launch patterns diverge from injectables
Novo Nordisk faces complex GLP-1 landscape as oral launch patterns diverge from injectables Proactive uses images sourced from…
Brazil approves first generic semaglutide pen after Ozempic patent expiry
SAO PAULO, May 26 (Reuters) – Brazil’s health regulator Anvisa said on Tuesday it had approved EMS’s Ozivy,…
Novo Nordisk faces new GLP-1 rival as Eli Lilly’s triple agonist sets weight-loss record
Novo Nordisk faces new GLP-1 rival as Eli Lilly’s triple agonist sets weight-loss record Proactive uses images sourced…
How GLP-1s are more than just weight-loss wonders – but not without risk
Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case
Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say
By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
Could Eli Lilly’s Next Weight Loss Drug Waylay Wegovy — and Even Zap Zepbound?
After losing its market edge to Eli Lilly (NYSE: LLY) despite its first-mover advantage in weight-loss drugs, Novo…
Best Healthcare Stocks to Buy in 2026
Biogen (NASDAQ: BIIB) and Novo Nordisk (NYSE: NVO) represent different opportunities within the healthcare sector: One is a…